Daniel Tardiff
Geen lopende functies
Profiel
Daniel Tardiff worked as a Research Head at Yumanity Therapeutics, Inc. before obtaining a doctorate degree from Brandeis University and an undergraduate degree from Stonehill College, Inc.
Eerdere bekende functies van Daniel Tardiff
| Bedrijven | Functie | Einde |
|---|---|---|
| YUMANITY THERAPEUTICS | Chief Tech/Sci/R&D Officer | - |
Opleiding van Daniel Tardiff
| Brandeis University | Doctorate Degree |
| Stonehill College, Inc. | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Yumanity Therapeutics, Inc.
 Yumanity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Yumanity Therapeutics, Inc. is a clinical stage biopharmaceuticals company. It is accelerating the revolution in the treatment of neurodegenerative diseases through its transformative scientific foundation and drug discovery platform. Its platform is based on technology, which enables the rapid screening for novel disease targets and disease modifying drugs that can overcome toxicity in disease-causing gene networks, which usually results from an aberrant accumulation of misfolded proteins in the brain. The company was founded by Susan Lindquist and Tony Coles in December 2014 and is headquartered in Boston, MA. | Health Technology |
